findmyKOL
Clinical trialNCT06111781RecruitingPhase 2Interventional

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

SponsorYale UniversityEnrollment60Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale Cancer Center

    New Haven, Connecticut, United States

    Yi An, MD
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    James Robert Janopaul-Naylor, MD
    Recruiting
  • University of Washington

    Seattle, Washington, United States

    Ting Martin Ma, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Apr 2024
Primary completion
29 Feb 2028
Completion
29 Feb 2028
Last update posted
11 May 2026
Registered enrollment
60
Registry id
NCT06111781
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.